Regenerative Medicine Offers Potential Medical Opportunities

Regenerative Medicine Offers Potential Medical Opportunities

Regenerative Medicine & Stem Cell Research

Doctors already treat serious illnesses with cord blood and placenta blood stem cells through hematopoietic reconstitution1,2 (the process of replacing diseased blood cells with healthy stem cells). However, investigational research is underway that may expand the applications for stem cells. It has already been demonstrated that higher quantities of stem cells result in higher rates of transplant success and survival.3 Soon, having more cells available may also prove beneficial for new treatments in the emerging medical field called regenerative medicine.4,5

Regenerative medicine, a changing force in the field of medical science, aims to restore human tissue and organs to full function. This is accomplished by replacing the damaged cells with healthy stem cells, repairing the body from within.

It’s expected that regenerative medicine will make significant advances over the next 10 to 20 years,6 and it could revolutionize healthcare as we know it. To learn more about regenerative medicine and its applications in stem cell research, visit Lifebank’s stem cells page.



  1. National Institutes of Health. Hematopoietic Stem Cells. Accessed December 23, 2020.
  2. Rocha V, Gluckman E; Eurocord-Netcord registry and European Blood and Marrow Transplant group. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft-and transplantation-related factors. Br J Haematol. 2009;147(2):262-274.
  3. Barker J. Combined effect of TNC and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood. 2010; 115:1843-1849.
  4. US Department of Health and Human Services. 2020: a new vision—a future for regenerative medicine. Accessed December 28, 2020.
  5. Harris DT, Badowski M, Ahmad N, et al. The potential of cord blood stem cells for use in regenerative medicine. Expert Opin Biol Ther. 2007;7(9): 1311-1322.
  6. Nietfeld JJ, Pasquini MC, Logan BR, et al. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biol Blood Marrow Transplant. 2008;14(3): 316-322.